Fixed dose combination Ciprofloxacin/Celecoxib

DRUG2 trials

Sponsors

NeuroSense Therapeutics Ltd.

Conditions

ALSALS (Amyotrophic Lateral Sclerosis)Amyotrophic Lateral Sclerosis

Phase 1

Ciprofloxacin/Celecoxib Combination in Patients With ALS

CompletedNCT04090684

NeuroSense Therapeutics Ltd.ALS (Amyotrophic Lateral Sclerosis)

Start: 2019-12-09End: 2022-01-20Updated: 2022-02-01

Phase 2

Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

CompletedNCT04165850

NeuroSense Therapeutics Ltd.ALS, Amyotrophic Lateral Sclerosis

Start: 2019-11-25End: 2021-01-19Updated: 2021-03-03